Marksans Pharma Reappoints Mark Saldanha as MD, Reinforces Strategic Continuity

Unknown Apr 02, 2026 3 Views

Leadership Renewal and Tenure Details Marksans Pharma Ltd has reappointed Mark Saldanha as Managing Director for a fresh five-year term, effective October 6, 2025, pending shareholder approval at the upcoming AGM. • The decision was finalized by the Board on July 25, 2025 •...